Published in Nature on January 27, 1994
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J (1997) 4.59
Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer (2013) 4.46
Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Oncol (2010) 3.11
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid (2015) 2.67
Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol (1994) 2.32
Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet (2001) 2.32
Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet (1994) 1.79
Fluorescence energy transfer detection as a homogeneous DNA diagnostic method. Proc Natl Acad Sci U S A (1997) 1.71
Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet (2000) 1.61
Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. Proc Natl Acad Sci U S A (1996) 1.58
Positive selection for new disease mutations in the human germline: evidence from the heritable cancer syndrome multiple endocrine neoplasia type 2B. PLoS Genet (2012) 1.55
Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J Cell Biol (2001) 1.52
Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. Genes Dev (2001) 1.51
How is the Human Genome Project doing, and what have we learned so far? Proc Natl Acad Sci U S A (1995) 1.50
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer. J Thyroid Res (2011) 1.46
Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest (1995) 1.46
Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol (1995) 1.44
Renal aplasia in humans is associated with RET mutations. Am J Hum Genet (2008) 1.41
Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol (2000) 1.28
Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. J Med Genet (1995) 1.26
Genetic basis of Hirschsprung's disease. Pediatr Surg Int (2009) 1.25
The RET-glial cell-derived neurotrophic factor (GDNF) pathway stimulates migration and chemoattraction of epithelial cells. J Cell Biol (1998) 1.22
Building a brain in the gut: development of the enteric nervous system. Clin Genet (2012) 1.21
Characterization of an activated mutant of focal adhesion kinase: 'SuperFAK'. Biochem J (2002) 1.20
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J Med Genet (1995) 1.17
Molecular pathways and therapeutic targets in lung cancer. Oncotarget (2014) 1.16
Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine. Am J Hum Genet (1997) 1.16
Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. Proc Natl Acad Sci U S A (1999) 1.15
Medullary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am (2007) 1.14
Genetics. One gene--four syndromes. Nature (1994) 1.11
A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet (2002) 1.09
Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases. Mol Biol Cell (2000) 1.08
Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas. Br J Cancer (2009) 1.08
Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J (1995) 1.07
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. Proc Natl Acad Sci U S A (1998) 1.07
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab (2013) 1.05
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol (2011) 1.05
Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). J Med Genet (1996) 1.04
Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease. Am J Hum Genet (1999) 1.04
A Drosophila model of multiple endocrine neoplasia type 2. Genetics (2005) 1.03
Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J (1996) 1.03
Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg (2007) 1.00
Parental origin effects, genome imprinting, and sex-ratio distortion: double or nothing? Am J Hum Genet (1994) 1.00
Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Proc Natl Acad Sci U S A (1997) 1.00
Genetic interactions and modifier genes in Hirschsprung's disease. World J Gastroenterol (2011) 0.99
Current understanding and management of medullary thyroid cancer. Oncologist (2013) 0.99
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst (2013) 0.98
C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J (2000) 0.98
Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am J Pathol (1994) 0.97
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. Proc Natl Acad Sci U S A (1996) 0.93
Clinicopathological and molecular histochemical review of skull base metastasis from differentiated thyroid carcinoma. Acta Histochem Cytochem (2013) 0.92
Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus. J Med Genet (1994) 0.92
Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism. Mol Cell Biol (1998) 0.92
Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. Am J Hum Genet (1994) 0.92
Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors. Front Oncol (2013) 0.91
Characterization of gene expression induced by RET with MEN2A or MEN2B mutation. Am J Pathol (2002) 0.91
Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected. Mol Cell Proteomics (2013) 0.90
Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb Perspect Biol (2013) 0.90
Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography. Neoplasia (2001) 0.89
Expression pattern of Drosophila ret suggests a common ancestral origin between the metamorphosis precursors in insect endoderm and the vertebrate enteric neurons. Proc Natl Acad Sci U S A (2001) 0.89
Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol (1995) 0.88
Role of vandetanib in the management of medullary thyroid cancer. Biologics (2012) 0.88
Medical management of metastatic medullary thyroid cancer. Cancer (2014) 0.88
Targeted agents in non-small cell lung cancer therapy: What is there on the horizon? J Carcinog (2013) 0.87
Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis. Oncotarget (2015) 0.86
Multiple endocrine neoplasia type 2: achievements and current challenges. Clinics (Sao Paulo) (2012) 0.86
Somatic deletion of the 5' ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagus. Am J Pathol (1998) 0.84
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma. Br J Cancer (1996) 0.84
Mapping of a novel MEN-like syndrome locus to rat chromosome 4. Mamm Genome (2004) 0.84
The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis. Mol Cell Biol (2001) 0.83
A newborn with ring chromosome 10, aganglionic megacolon, and renal hypoplasia. J Med Genet (1994) 0.83
Molecular basis of medullary thyroid carcinoma: the role of RET polymorphisms. Int J Mol Sci (2011) 0.83
Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg (2004) 0.83
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers. Curr Genomics (2011) 0.82
A unique RET EXON 11 (G691S) polymorphism in an Indian patient with a collision tumor of the thyroid. Diagn Pathol (2007) 0.82
Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations. Ann Surg (2002) 0.82
Translational research in endocrine surgery. Surg Oncol Clin N Am (2013) 0.81
Upregulation of the PI3K/Akt pathway in the tumorigenesis of canine thyroid carcinoma. J Vet Intern Med (2014) 0.81
Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue. Br J Cancer (2002) 0.81
Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer. Wien Klin Wochenschr (2006) 0.81
AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines. PLoS One (2012) 0.80
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluation. Eur J Med Chem (2014) 0.80
A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B. Biochem J (1996) 0.80
Two siblings below the age of 20 years with diverticular disease. Int J Colorectal Dis (2005) 0.79
Genetic alterations in a primary medullary thyroid carcinoma and its lymph node metastasis in a patient with 15 years follow-up. Diagn Pathol (2012) 0.79
Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors. Dig Dis Sci (1998) 0.79
Congenital sucrase-isomaltase deficiency presenting with failure to thrive, hypercalcemia, and nephrocalcinosis. BMC Pediatr (2002) 0.79
Genetic mapping of the RET protooncogene on rat chromosome 4. Mamm Genome (1995) 0.79
RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer (1996) 0.79
Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid (2014) 0.79
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers. BMC Cancer (2014) 0.78
[Molecular biology, basic research and diagnosis of Hirschsprung's disease]. Pathologe (2007) 0.78
PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling. Br J Pharmacol (2014) 0.78
Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer. Thyroid (2014) 0.78
Absence of the RET+3:T allele in the MTC patients. Hered Cancer Clin Pract (2012) 0.78
The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases. Endocr Pathol (1996) 0.77
Reduced USP39 expression inhibits malignant proliferation of medullary thyroid carcinoma in vitro. World J Surg Oncol (2015) 0.77
Hirschsprung's disease as a neurochristopathy. Pediatr Surg Int (1997) 0.77
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem (2000) 4.24
Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet (2007) 4.13
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet (1994) 4.11
Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med (2001) 3.96
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem (1998) 3.83
SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet (1998) 3.82
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (2000) 3.50
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.46
Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37
MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet (2000) 3.35
GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell (1996) 2.86
Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13, and alpha 1-acid glycoprotein to chromosome 9. Hum Genet (1986) 2.84
Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell (1992) 2.77
A randomized trial on root caries prevention in elders. J Dent Res (2010) 2.74
Non-inactivation of an x-chromosome locus in man. Science (1979) 2.74
Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A (1999) 2.70
Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med (1998) 2.56
Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature (1988) 2.47
Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet (1997) 2.45
A microsatellite genetic linkage map of human chromosome 18. Genomics (1993) 2.35
A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet (1994) 2.30
Chemical mapping of a single molecule by plasmon-enhanced Raman scattering. Nature (2013) 2.19
Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci (2000) 2.06
Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Oncogene (2007) 2.03
Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med (1994) 1.97
Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications. J Biol Chem (1999) 1.93
PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet (2004) 1.91
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Stable length polymorphism of up to 260 kb at the tip of the short arm of human chromosome 16. Cell (1991) 1.87
Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol (1999) 1.85
The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature (1996) 1.84
A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet (1998) 1.81
Molecular basis for the explanation of the exponential growth of polyelectrolyte multilayers. Proc Natl Acad Sci U S A (2002) 1.80
A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet (1993) 1.79
Purified human factor activates heat shock promoter in a HeLa cell-free transcription system. J Biol Chem (1988) 1.74
Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation (2000) 1.70
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer (2011) 1.69
Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet (2001) 1.68
Dominant effector genetics in mammalian cells. Nat Genet (2001) 1.68
Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res (1998) 1.68
Three novel proteins of the syntaxin/SNAP-25 family. J Biol Chem (1998) 1.67
Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT-PCR. Biotechniques (2000) 1.66
Detection of programmed cell death using fluorescence energy transfer. Nucleic Acids Res (1998) 1.65
A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet (1996) 1.65
Structural and functional aspects of the multiplicity of Neu differentiation factors. Mol Cell Biol (1994) 1.64
Islet amyloid polypeptide: identification and chromosomal localization of the human gene. FEBS Lett (1988) 1.63
Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease. Science (1970) 1.61
Physical mapping of the human chromosome 11q23 region containing the ataxia-telangiectasia locus. Cancer Genet Cytogenet (1990) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
A second human calcitonin/CGRP gene. FEBS Lett (1985) 1.60
Two high-resolution crystal structures of the recombinant N-lobe of human transferrin reveal a structural change implicated in iron release. Biochemistry (1998) 1.57
MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene (2011) 1.54
The structure of human pancreatic alpha-amylase at 1.8 A resolution and comparisons with related enzymes. Protein Sci (1995) 1.54
Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells. J Immunol (1997) 1.53
Phenotypic intrafamilial heterogeneity in cystic fibrosis. Clin Genet (1993) 1.53
Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. Cancer Res (1999) 1.52
Earthquake in a maze: compressional rupture branching during the 2012 M(w) 8.6 Sumatra earthquake. Science (2012) 1.52
ART and conventional root restorations in elders after 12 months. J Dent Res (2006) 1.50
TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton. J Biol Chem (1999) 1.50
Minimum length of sequence homology required for in vivo cloning by homologous recombination in yeast. Plasmid (1997) 1.49
Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol (1997) 1.48
Localization of the polymorphic human calcitonin gene on chromosome 11. Hum Genet (1984) 1.46
Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ (1999) 1.46
Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol (2000) 1.45
A specialized pathway affecting virulence glycoconjugates of Leishmania. Science (1995) 1.45
Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years. Curr Med Chem (2010) 1.45
Recombinations between IRP and cystic fibrosis. Am J Hum Genet (1988) 1.44
Incidence of Friedreich ataxia in Italy estimated from consanguineous marriages. Am J Hum Genet (1983) 1.44
The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem Photobiol (1997) 1.43
DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res (1986) 1.43
Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet (1997) 1.42
The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAs. J Biol Chem (2000) 1.42
Change in paternity and select perinatal outcomes: causal or confounded? J Obstet Gynaecol (2012) 1.42
Overexpression of Pim-1 during progression of prostatic adenocarcinoma. J Clin Pathol (2006) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Incidence in Italy, genetic heterogeneity, and segregation analysis of cystic fibrosis. Am J Hum Genet (1985) 1.41
Field reversed configuration confinement enhancement through edge biasing and neutral beam injection. Phys Rev Lett (2012) 1.41
p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene (2001) 1.41
A complex containing two transcription factors regulates peroxisome proliferation and the coordinate induction of beta-oxidation enzymes in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Use of BICAP in a case of colon angiodysplasia. Surg Endosc (1991) 1.39
Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol (2000) 1.39
Dynamic formation of a hot field reversed configuration with improved confinement by supersonic merging of two colliding high-β compact toroids. Phys Rev Lett (2010) 1.38
Cancer genetic counselling. Ann Oncol (2005) 1.38
A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology (1990) 1.38